The influence of 1-[3-(1-cyclohexenyl)-3-phenylpropyl]-1-methylpiperidinium bromide (HOE 019) on gastric secretion in the rat.
D000758:Anesthesia; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D002217:Carbachol / Q000037:antagonists & inhibitors; D003510:Cyclohexanes / Q000494:pharmacology; D003864:Depression, Chemical; D004558:Electric Stimulation; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa / Q000378:metabolism*; D006632:Histamine / Q000494:pharmacology; D007329:Insulin Antagonists; D008297:Male; D010276:Parasympatholytics / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D011708:Pylorus / Q000502:physiology; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects; D013268:Stimulation, Chemical; D014630:Vagus Nerve
D003510:Cyclohexanes; D007329:Insulin Antagonists; D010276:Parasympatholytics; D010880:Piperidines; D001285:Atropine; D006632:Histamine; D002217:Carbachol